euglena Co. is a TSE-listed biotech company with the management philosophy 'make people and the planet healthy,' and the first in the world to establish outdoor mass-culture technology for the microalga euglena (Japanese name midorimushi). It sells functional foods and cosmetics made with euglena and advances R&D on biofuel. The founding spark was the child-nutrition problem its head witnessed in Bangladesh. Continuing from that origin is the 'euglena GENKI Program'—it directs part of the sales of its own products to sponsorship funds and distributes nutritious euglena-containing cookies free to children in Bangladesh who tend to lack nutrition. Spreading from the capital Dhaka to 12 rural districts, it has 106 partner schools, reaches about 10,000 children a day, and reached 8.5 million cumulative meals (as of 2019). Grameen Euglena, formed with the Grameen group, also works on raising local farmers' incomes.
●●○ medium
There is no confirmed −; independently verified + decide the position (C). No unreachable strike-through.= non-additive meter
euglena Co.: Nutrition and fuel from euglena—a plus embedded in commerce. The letter is C; certainty is medium. Unconfirmed concerns are placed under “Watching.” (As of 2026-Q3; estimate based on public information.)
Main narrative
One person’s story (N1)
+ A single story
In Bangladesh's slums, cheap and abundant rice is the diet's center, so protein, vitamins and minerals tend to be lacking. Through the GENKI Program, euglena-containing cookies are handed out as school meals at elementary schools in undernourished areas, and six cookies per serving supplement a day's worth of scarce nutrients. The benefit appears as a collective: it reaches 106 partner schools and about 10,000 children a day, reaching 8.5 million cumulative meals.
Source nature: JICA(mundi) / P1 Independent (JICA). Positive effects are not used to offset negatives.
Positive / negative effects
+ effects
- The GENKI Program, begun in 2014, directs part of the sales of the company's and group's products (food and cosmetics) to sponsorship funds, distributing euglena cookies free to Bangladeshi children. It spread from Dhaka to 12 rural districts, 106 partner schools, about 10,000 a day. In 2024 it also launched GENKI-Yell, a corporate donation scheme. There is also a joint venture with the Grameen group for local-farmer income.P1 First-party
− effects (confirmed)
- No confirmed −.
- A
- l
- i
- s
- t
- e
- d
- ,
- f
- o
- r
- -
- p
- r
- o
- f
- i
- t
- c
- o
- m
- m
- e
- r
- c
- i
- a
- l
- b
- i
- o
- t
- e
- c
- h
- (
- m
- a
- i
- n
- b
- u
- s
- i
- n
- e
- s
- s
- =
- h
- e
- a
- l
- t
- h
- f
- o
- o
- d
- /
- c
- o
- s
- m
- e
- t
- i
- c
- s
- /
- b
- i
- o
- f
- u
- e
- l
- )
- ;
- G
- E
- N
- K
- I
- i
- s
- s
- a
- l
- e
- s
- -
- l
- i
- n
- k
- e
- d
- s
- p
- o
- n
- s
- o
- r
- s
- h
- i
- p
- ,
- i
- n
- t
- e
- g
- r
- a
- t
- e
- d
- w
- i
- t
- h
- m
- a
- r
- k
- e
- t
- i
- n
- g
- ;
- a
- c
- o
- n
- t
- e
- x
- t
- o
- f
- s
- k
- e
- p
- t
- i
- c
- i
- s
- m
- o
- v
- e
- r
- e
- u
- g
- l
- e
- n
- a
- e
- f
- f
- i
- c
- a
- c
- y
- /
- b
- i
- o
- f
- u
- e
- l
- f
- e
- a
- s
- i
- b
- i
- l
- i
- t
- y
- a
- n
- d
- s
- h
- a
- r
- e
- -
- p
- r
- i
- c
- e
- d
- i
- s
- p
- u
- t
- e
- s
- (
- s
- h
- o
- r
- t
- -
- s
- e
- l
- l
- e
- r
- r
- e
- p
- o
- r
- t
- s
- ,
- e
- t
- c
- .
- )
- .
- Third-party verification of GENKI Program nutrition outcomes; expanding a non-sales-linked support base (GENKI-Yell, etc.); realizing the biofuel business; transparency on efficacy/environmental claims.
A second look
The plus is nutritional support for children in Bangladesh (the GENKI Program: 8.5 million cumulative meals, 106 schools, about 10,000 a day) and income improvement for local farmers (People), a real activity even featured by JICA. However, this is the CSR of a TSE-listed commercial biotech company whose main business is health food, cosmetics and biofuel; the GENKI Program is a sponsorship-fund model tied to product sales (integrated with marketing); and it is a field with skepticism and share-price disputes (short-seller reports, etc.) over euglena health-food efficacy and biofuel feasibility—the nutrition support is genuine but deeply embedded in commerce, with the 'make people and the planet healthy' story running somewhat ahead of the reality, so C/medium rather than B. It does not reach a confirmed minus.
Sources
How to read this assessment
- Reachable upper bound (ceiling): a confirmed − sets the ceiling, and independently verified + decide the position within it. + do not cancel out −.
- The weight of evidence is not symmetric: only confirmed − are counted; the volume of disputes or allegations goes under “Watching.” + are counted from independent evidence, while an organization’s own PR is treated as “reference.”
- Size is not value: scale is not used in the assessment. Matters that stay within money or competition—investors, shareholders, sanctions, trade secrets—are also excluded.
- The letter (assessment) and certainty (how reliable the information is) are separate axes.
This is a translation; the Japanese version is authoritative. The assessments here are generated automatically by AI based on published criteria. The operator does not alter individual results. Because they are AI-generated they may contain errors, and they are opinion and commentary, not statements of fact. Where evidence is insufficient, the entry is marked “On hold.” Requests for correction are accepted via the form.
Terms: Narrative Value = an assessment (A–G) of the distance between the story an organization tells and its reality / Ceiling meter = a visualization of the reachable upper bound / Watching = unconfirmed matters not counted / Protected stakeholders = people, animals, nature, and future generations. | Generated by: AI | As of: 2026-Q3 | Back to top